Detalhe da pesquisa
1.
Performance of cardiovascular disease risk prediction equations in more than 14â000 survivors of cancer in New Zealand primary care: a validation study.
Lancet
; 401(10374): 357-365, 2023 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36702148
2.
Ethnic differences in the characteristics of patients with newly diagnosed lung cancer in the Te Manawa Taki region of New Zealand.
Intern Med J
; 54(3): 421-429, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37584463
3.
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.
BMC Cancer
; 20(1): 658, 2020 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32664868
4.
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non-small-cell lung cancer in New Zealand.
Intern Med J
; 50(6): 716-725, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31318119
5.
Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed.
J Struct Biol
; 192(3): 539-544, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26522274
6.
Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity.
J Neurochem
; 135(6): 1099-112, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26364854
7.
Emerging roles of metal solute carriers in cancer mechanisms and treatment.
Biopharm Drug Dispos
; 35(8): 450-62, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24889085
8.
Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients.
BMC Cancer
; 13: 495, 2013 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-24156389
9.
Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Clin Exp Pharmacol Physiol
; 40(6): 371-8, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23556474
10.
Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients.
Cancer Med
; 12(19): 20081-20093, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37746882
11.
Invitation methods for Indigenous New Zealand Maori in lung cancer screening: Protocol for a pragmatic cluster randomized controlled trial.
PLoS One
; 18(8): e0281420, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37527237
12.
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.
BMC Cancer
; 12: 496, 2012 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-23098625
13.
Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study.
Lancet Reg Health West Pac
; 24: 100522, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35832510
14.
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.
Clin Cancer Res
; 28(12): 2506-2516, 2022 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35091443
15.
Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
J Pharmacol Exp Ther
; 338(2): 537-47, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21606177
16.
A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients.
BMC Cancer
; 11: 432, 2011 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-21982454
17.
Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Maori and Pacifica in New Zealand.
PLoS One
; 16(5): e0251357, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33961689
18.
Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
Mol Pain
; 6: 53, 2010 Sep 13.
Artigo
Inglês
| MEDLINE | ID: mdl-20836889
19.
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
BMC Cancer
; 10: 451, 2010 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-20731872
20.
ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy.
Future Oncol
; 6(10): 1537-43, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21062153